Evaluation of oncology infusion pharmacy practices: A nationwide survey

Author:

Boyd AM1ORCID,Sue C2,Khandoobhai A3,Vinson B4,Shaikh H5,Sorenson S6,Patel V4,Snyder B78,Bondarenka C9,Koukounas Y110,Earl M111,Jenkins M12

Affiliation:

1. Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA

2. Department of Pharmacy, UC Health, Cincinnati, OH, USA

3. Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA

4. Department of Pharmacy, Cedars-Sinai, Los Angeles, CA, USA

5. Department of Pharmacy, University Health, Kansas City, MO, USA

6. Department of Pharmacy, University of Iowa Health Care, Iowa City, IA, USA

7. Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA

8. Bristol-Meyers Squibb Company, New York, NY, USA

9. Department of Pharmacy, Medical University of South Carolina, Charleston, SC, USA

10. Novartis, Basel, Switzerland

11. Seagen, Bothell, WA, USA

12. Department of Pharmacy Services, UVA Health, Charlottesville, VA, USA

Abstract

Purpose Oncology care continues to evolve at a rapid pace including provision of infusion-based care. There is currently a lack of robust metrics around oncology infusion centers and pharmacy practice. The workgroup completed a nationwide survey to learn about oncology-based infusion pharmacy services offered. The objective was to highlight consistent, measureable oncology-based infusion pharmacy metrics that will provide a foundation to describe overall productivity including emphasis on high patient-safety standards. Methods A nationwide survey was developed via a workgroup within the Vizient Pharmacy Cancer Care Group beginning in April 2019 and conducted electronically via the Vizient Pharmacy Network from September to November 2020. The survey was designed to capture a number of key metrics related to oncology-based infusion pharmacy services. Results Forty-one sites responded to the survey. Responses highlighted hours of operation (median = 11.5), number of infusion chairs (median = 45). Staffing metrics included 7.1 pharmacist full-time equivalent (FTE) and 7.6 technician FTE per week. 80.5% of sites had cleanrooms and 95.1% reported both hazardous and nonhazardous compounding hoods. 68.3% of sites reported using intravenous (IV) technology, 50.0% measured turnaround time, and 31.4% prepared treatment medications in advance. Conclusion There was variability among oncology infusion pharmacy practices in regard to survey responses among sites. The survey results highlight the need for standardization of established productivity metrics across oncology infusion pharmacies in order to improve efficiency and contain costs in the changing oncology landscape. The survey provides insight into oncology infusion pharmacy practices nationwide and provides information for pharmacy leaders to help guide their practices.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Reference56 articles.

1. NIH: National Cancer Institute. Cancer statistics 2020. https://www.cancer.gov/about-cancer/understanding/statistics (2020, accessed 5 February 2023).

2. Did Changes in Drug Reimbursement After the Medicare Modernization Act Affect Chemotherapy Prescribing?

3. ASCO: American Society of Clinical Oncology. ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic. https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf (2021, accessed 5 February 2023).

4. Actions - H.R.1900 - 98th Congress (1983–1984): Social Security Amendments of 1983. (1983, April 20). https://www.congress.gov/bill/98th-congress/house-bill/1900/all-actions. Accessed on 5 February 2023.

5. Guidelines for Hospitalization for Chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3